Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Statistics for Sunday's Japanese Formula One Grand Prix at the Suzuka circuit, third race of the season: Wheatley steps down as Audi team principal for personal reasons Jonathan Wheatley has departed ...

Few sports capture the exhilaration of nations like Formula One. From blistering battles down the straight to canny moves in the corners, the biggest motorsport carnival in the world is back again for ...